
March 27 (Reuters) - Rigel Pharmaceuticals Inc RIGL.O:
RIGEL ANNOUNCES SETTLEMENT AGREEMENT RESOLVING TAVALISSE® (FOSTAMATINIB DISODIUM HEXAHYDRATE) PATENT LITIGATION
RIGEL PHARMACEUTICALS INC - UNDER SETTLEMENT, ANNORA TO SELL GENERIC TAVALISSE IN Q2 2032 OR EARLIER
RIGEL PHARMACEUTICALS INC - CO AND ANNORA TERMINATE ALL ONGOING LITIGATION REGARDING TAVALISSE PATENTS